SMS Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has submitted a statement to the Exchange regarding deviations or variations in the use of proceeds, as required under Regulation 32 of the SEBI Listing Obligations and Disclosure Requirements (LODR). This regulation applies to funds raised through public issues, rights issues, or preferential allotments, where the company must report if the actual use of funds differs from what was originally disclosed. The filing indicates the company is complying with disclosure norms about any gap between planned and actual deployment of issue proceeds. The exact nature and quantum of the deviation are not specified in the headline and would be detailed in the full filing.
For shareholders, this is a routine compliance filing and is largely neutral. However, the underlying deviation in fund usage should be reviewed, as significant variations from stated objectives can raise governance concerns and may affect investor confidence in the company's capital allocation discipline.